Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00497159 · ClinicalTrials.gov registry record · Phase 2
A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
A Phase 2 study, sponsored by Medivation.
- Completed
- Registry status
- Phase 2
- Development phase
- 91
- Enrollment target
NCT00497159 is a Phase 2 study that has completed, run by Medivation. The registered enrollment target is 91 participants.
The verdict
NCT00497159, a Phase 2 study, has completed, sponsored by Medivation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 91 participants
- Enrollment target
Study Summary
This study will evaluate the safety of 3 months of Dimebon dosing and the efficacy of Dimebon in improving cognitive, motor, and overall function in subjects with Huntington's Disease.
Interventions
- OTHER Placebo
- DRUG Dimebon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00497159
The ClinicalTrials.gov registry entry for NCT00497159 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medivation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00497159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00497159 about?
NCT00497159 is a clinical study titled "A Study of the Novel Drug Dimebon in Patients With Huntington's Disease". This study will evaluate the safety of 3 months of Dimebon dosing and the efficacy of Dimebon in improving cognitive, motor, and overall function in subjects with Huntington's Disease.
What is the current status of trial NCT00497159?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 91 participants. The study started on 2007-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00497159?
The interventions under investigation include: Placebo (OTHER), Dimebon (DRUG).
Who is sponsoring clinical trial NCT00497159?
This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.